Sirolimus-eluting stents for chronic total coronary occlusions: a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of chronic total coronary occlusions (PRISON II)
Latest Information Update: 09 Sep 2012
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms PRISON-II
- 29 Aug 2012 Five-year angiographic results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
- 01 Apr 2008 Results presented at ACC in 2008
- 26 Jun 2007 New trial record.